Literature DB >> 17024849

Protoberberine alkaloids and their reversal activity of P-gp expressed multidrug resistance (MDR) from the rhizome of Coptis japonica Makino.

Yong Deuk Min1, Min Cheol Yang, Kyu Ha Lee, Kyung Ran Kim, Sang Un Choi, Kang Ro Lee.   

Abstract

Six protoberberine alkaloids were isolated from the chloroform layer of the rhizome of Coptis japonica Makino (Ranunculaceae). The structures of the isolated compounds were determined to be 6-([1,3]dioxolo[4,5-g]isoquinoline-5-carbonyl)-2,3-dimethoxy-benzoic acid methyl ester (1), oxyberberine (2), 8-oxo-epiberberine (3), 8-oxocoptisine (4), berberine (5) and palmatine (6) by physicochemical and spectroscopic methods. The compound 3 (8-oxo-epiberberine) was first isolated from natural sources. The compounds were tested for cytotoxicity against five tumor cell lines in vitro by SRB method, and also tested for the MDR reversal activities. Compound 4 was of significant P-gp MDR inhibition activity with ED50 value 0.018 microg/mL in MES-SA/DX5 cell and 0.0005 microg/mL in HCT15 cell, respectively.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17024849     DOI: 10.1007/BF02974076

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  19 in total

1.  Alkaloids of Dicranostigma franchetianum (Papaveraceae) and Berberine Derivatives as a New Class of Antimycobacterial Agents.

Authors:  Viriyanata Wijaya; Ondřej Janďourek; Jana Křoustková; Kateřina Hradiská-Breiterová; Jan Korábečný; Kateřina Sobolová; Eliška Kohelová; Anna Hošťálková; Klára Konečná; Marcela Šafratová; Rudolf Vrabec; Jiří Kuneš; Lubomír Opletal; Jakub Chlebek; Lucie Cahlíková
Journal:  Biomolecules       Date:  2022-06-17

Review 2.  Drug Resistance in Colorectal Cancer: From Mechanism to Clinic.

Authors:  Qianyu Wang; Xiaofei Shen; Gang Chen; Junfeng Du
Journal:  Cancers (Basel)       Date:  2022-06-14       Impact factor: 6.575

3.  Secondary Metabolites from Plants Inhibiting ABC Transporters and Reversing Resistance of Cancer Cells and Microbes to Cytotoxic and Antimicrobial Agents.

Authors:  Michael Wink; Mohamed L Ashour; Mahmoud Zaki El-Readi
Journal:  Front Microbiol       Date:  2012-04-23       Impact factor: 5.640

4.  The Zuo Jin Wan Formula Induces Mitochondrial Apoptosis of Cisplatin-Resistant Gastric Cancer Cells via Cofilin-1.

Authors:  Qing-Feng Tang; Jian Sun; Hui Yu; Xiao-Jing Shi; Rong Lv; Hong-Chang Wei; Pei-Hao Yin
Journal:  Evid Based Complement Alternat Med       Date:  2016-10-30       Impact factor: 2.629

Review 5.  Natural Products as Alternative Choices for P-Glycoprotein (P-gp) Inhibition.

Authors:  Saikat Dewanjee; Tarun K Dua; Niloy Bhattacharjee; Anup Das; Moumita Gangopadhyay; Ritu Khanra; Swarnalata Joardar; Muhammad Riaz; Vincenzo De Feo; Muhammad Zia-Ul-Haq
Journal:  Molecules       Date:  2017-05-25       Impact factor: 4.411

6.  Interaction of herbal compounds with biological targets: a case study with berberine.

Authors:  Xiao-Wu Chen; Yuan Ming Di; Jian Zhang; Zhi-Wei Zhou; Chun Guang Li; Shu-Feng Zhou
Journal:  ScientificWorldJournal       Date:  2012-11-13

7.  Zuo Jin Wan, a Traditional Chinese Herbal Formula, Reverses P-gp-Mediated MDR In Vitro and In Vivo.

Authors:  Hua Sui; Xuan Liu; Bao-Hui Jin; Shu-Fang Pan; Li-Hong Zhou; Nikitin Alexander Yu; Jie Wu; Jian-Feng Cai; Zhong-Ze Fan; Hui-Rong Zhu; Qi Li
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-04       Impact factor: 2.629

8.  Synergistic Effect of Zuo Jin Wan on DDP-Induced Apoptosis in Human Gastric Cancer SGC-7901/DDP Cells.

Authors:  Qing-Feng Tang; Qing Ji; Yan-Yan Qiu; Ai-Li Cao; Yang-Feng Chi; Bo Liang; Wen Peng; Pei-Hao Yin
Journal:  Evid Based Complement Alternat Med       Date:  2014-03-03       Impact factor: 2.629

9.  Zuo Jin Wan reverses P-gp-mediated drug-resistance by inhibiting activation of the PI3K/Akt/NF-κB pathway.

Authors:  Hua Sui; Shu-Fang Pan; Yu Feng; Bao-Hui Jin; Xuan Liu; Li-Hong Zhou; Feng-Gang Hou; Wen-Hai Wang; Xiao-Ling Fu; Zhi-Fen Han; Jian-Lin Ren; Xiao-Lan Shi; Hui-Rong Zhu; Qi Li
Journal:  BMC Complement Altern Med       Date:  2014-08-01       Impact factor: 3.659

10.  Uncommon presentation of potential medication-related osteonecrosis of the jaw.

Authors:  Seong-Gon Kim; HaeYong Kweon; Suk-Keun Lee
Journal:  Springerplus       Date:  2016-02-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.